West Paces Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-72
| Closed | -$5.95K | – | 543 |
|
|
2022
Q3 | $5.95K | Hold |
72
| – | – | ﹤0.01% | 377 |
|
|
2022
Q2 | $6.85K | Hold |
72
| – | – | ﹤0.01% | 392 |
|
|
2022
Q1 | $8.48K | Hold |
72
| – | – | ﹤0.01% | 380 |
|
|
2021
Q4 | $9.33K | Sell |
72
-30
| -29% | -$3.89K | ﹤0.01% | 383 |
|
|
2021
Q3 | $11.5K | Hold |
102
| – | – | ﹤0.01% | 346 |
|
|
2021
Q2 | $10.6K | Hold |
102
| – | – | ﹤0.01% | 353 |
|
|
2021
Q1 | $8.53K | Hold |
102
| – | – | ﹤0.01% | 345 |
|
|
2020
Q4 | $9.31K | Hold |
102
| – | – | ﹤0.01% | 323 |
|
|
2020
Q3 | $8.14K | Hold |
102
| – | – | ﹤0.01% | 322 |
|
|
2020
Q2 | $7.05K | Hold |
102
| – | – | ﹤0.01% | 344 |
|
|
2020
Q1 | $6.41K | Hold |
102
| – | – | ﹤0.01% | 340 |
|
|
2019
Q4 | $7.93K | Hold |
102
| – | – | ﹤0.01% | 370 |
|
|
2019
Q3 | $7.48K | Hold |
102
| – | – | ﹤0.01% | 352 |
|
|
2019
Q2 | $6.28K | Hold |
102
| – | – | ﹤0.01% | 361 |
|
|
2019
Q1 | $6.51K | Hold |
102
| – | – | ﹤0.01% | 361 |
|
|
2018
Q4 | $5.21K | Hold |
102
| – | – | ﹤0.01% | 374 |
|
|
2018
Q3 | $5.92K | Hold |
102
| – | – | ﹤0.01% | 366 |
|
|
2018
Q2 | $4.95K | Buy |
102
+30
| +42% | +$1.46K | ﹤0.01% | 385 |
|
|
2018
Q1 | $3.35K | Hold |
72
| – | – | ﹤0.01% | 396 |
|
|
2017
Q4 | $2.71K | Sell |
72
-84
| -54% | -$3.16K | ﹤0.01% | 416 |
|
|
2017
Q3 | $5.68K | Sell |
156
-69
| -31% | -$2.51K | ﹤0.01% | 378 |
|
|
2017
Q2 | $8.87K | Hold |
225
| – | – | 0.01% | 349 |
|
|
2017
Q1 | $7.06K | Sell |
225
-27
| -11% | -$847 | 0.01% | 362 |
|
|
2016
Q4 | $7.87K | Buy |
+252
| New | +$7.87K | 0.01% | 363 |
|